|
Comparisions of the severity of psoriasis with metabolic comorbidities in kanchipuram district
|
|
| Author:
|
ANJUMEENA D, MARIA ANNITA TELLCOTT
|
| Abstract:
|
Severe psoriasis has a 50% improved risk of mortality that outcomes in death within 50 years. Obesity per se is a
risk factor for emergent psoriasis in about 30% of patients. All these metabolic disorders may lead to worsening of
severity of psoriasis. Given the suggestionamong psoriasis and metabolic syndrome, it is important to screen all the
patients with psoriasis as part of routine medical care and thereby take measures at lowering cardiovascular risk at
the earliest.The objective of my study was to evaluate the clinical and laboratory parameters associated with
metabolic co morbidities and their relationship with Psoriasis.Factors causing disparity in Variation of the
prevalence of psoriasis include age, gender, geomorphology, and ethnicity, genetic and environmental factors.
Higher incidence fees were located at better latitudes and in Caucasians in contrast with other ethnic
businesses.Informed consent was obtained from all the patients, history of duration of psoriasis, past history, family
history and treatment history were noted down. Height and weight were measured and BMI was calculated. Waist
circumference was measured. Blood pressure was recorded. The blood investigations and electrocardiogram were
also taken.The total number of patients in my study was 106.Out of which 56.6% had association with metabolic
syndrome and 30.2% had ECG abnormalities. Both genders were equally affected. Most of the patients (32%) were
between the age group of 58 to 67 years. The duration of psoriasis ranged from 1 month to 15 years. The mean (±
standard deviation) duration of psoriasis was 5.9 years (±3.8 years) Psoriasis vulgaris was the most common type
81.1% out of which severe psoriasis was seen in most of the patients (39.6%).Nail changes were seen in 49.1%.
Allowing to NCEP ATP III criteria, metabolic syndrome was present in more than half of the patients (56.6%).
|
| Keyword:
|
ATP III (Adult treatment Panel),National Cholesterol Education Program,metabolic syndrome,BMI,blood investigations and electrocardiogram
|
| EOI:
|
-
|
| DOI:
|
-
|
| Download:
|
Request For Article
|
|
|